Cross-industry discussion is expanding from early discovery to post-licensing challenges – as the nexus of innovation and policy improvements is rapidly changing, says DIA executive.
Japan-based ONO Pharmaceutical will use CluePoints’ centralized statistical monitoring platform to lead its RBM strategy over the next four years following a successful pilot study in 2017.
GlaxoSmithKline has selected TrialScope to facilitate clinical trial disclosure and transparency – as the benefits of patient centricity are paramount, and the risks of poor compliance magnified, says VP.
CRO Pivotal is collaborating with the non-profit cancer research association APRO to advance investigator-sponsored trials in bladder and prostate cancers.
PPD has launched a new site solution for enrolling patients in clinical studies as it proposes enrolling patients first – before activating sites – via a new enrollment model.
Patient-centric programs for clinical trials, such as travel assistance, are major deciding factors for patients considering participation – and should be standard for all studies, says BBK.
Innovations in drug development positively affect clinical trial timelines, market launch likelihood, and patient access – though adoption remains low, says report.
Clinipace has launched a new branding for its collaborative approach to clinical trial management, which will “contribute to its goal of becoming the industry’s premier mid-sized CRO,” says CEO.
There is an increased need for transparency to improve the conduct of pediatric clinical trials and enhance the site investigator experience, says Syneos executive.
Iqvia has launched a new suite of virtual study options to challenge the traditional clinical research mindset with a patient-centric approach, says company executive.
Javara today has emerged as the latest company to take on the clinical trials industry – though backed by a group of industry veterans, it is not a startup, and its goals not short of transformational.
LabConnect and Symphony Clinical Research are teaming up to improve the delivery of home-based clinical trials by co-developing new processes and tools.
ACM Global Laboratories has acquired ABS Laboratories to better serve its clients in the clinical trial market with an expanded "scientific acumen," says company president.
Elligo Health Research is partnering with Flatiron Health and the University of Chicago to develop and pilot a common data architecture as part of an FDA-led project.
The rule designed to increase protection for clinical trial participants was set to go into effect next month, but another delay announced today has pushed this date back an additional six months.
Real-world evidence, digital endpoints, and patient centricity are among the top trends in clinical trials – the benefits of which will be realized in part through advances in eClinical technology.
This year’s DIA Global Annual Meeting will focus on the latest global trends and showcase the "diverse group of key individuals driving the life science ecosystem forward," says DIA Americas managing director.
The drug development “finish line” is not regulatory approval, says Syenos Health chief scientific officer Judith Ng-Cashin, MD, who discusses bringing the payer and patient voice into the process.
The NIH has halted funding for a clinical trial – funded in part by several beverage and brewing companies – after a review found employees violated NIH policies in soliciting gift funding.
Medidata is acquiring Shyft Analytics for $195m, creating a new platform that will combine clinical development with commercial and real-world data analytics in a first for the industry, says a company executive.
The Croatia-headquartered contract research organization (CRO) has opened its first office in the US and plans to further expand its footprint organically and through potential acquisitions.
Saama has launched a set of artificial intelligence (AI) capabilities designed to understand "typical life science domain questions" to better support clinical trial planning, feasibility, and conduct.
Alcami began work on Flexion Therapeutics's ZILRETTA in the fall of 2014 and today announced that it will further support commercial supply of the product, which is approved for the treatment of OA-related knee pain.
Following on from the success of last year's survey, Outsourcing-Pharma is running another 'state of the industry' survey to gauge views about the current state of the pharmaceutical contract services industry.
SIGA is slated to receive FDA approval for the world’s first antiviral drug to treat smallpox – a milestone not reached in isolation, but in collaboration with several CROs, government agencies, and others.
PPD Laboratories SVP says its been a substantial undertaking – for every company in the CRO industry – to meet the demand for biopharmaceuticals as the industry's pipeline continues to expand.
China’s pharmaceutical market has outpaced Japan’s to become the second largest market globally – as both aim to be the location of choice for companies developing new innovations, say Parexel consultants.
AMRI will support the development and manufacture of active pharmaceutical ingredients (API) and drug product for Phase I clinical studies under a seven-year contract with the NIH.
Celltrion has launched Bio CDMO, its new contract development and manufacturing business and part of the company's "open innovation strategy" to expand its drug pipeline portfolio.
Ergomed has added specialist pharmacoepidemiology services at its PrimeVigilance subsidiary to support increasing demand from regulators globally, says CEO.
Altasciences has entered into a strategic alliance with Altreos Research Partners to help clients navigate the “complexities of human abuse potential studies,” says CEO.
Several teams recently competed in the Popup Star clinical trial awareness contest to help raise grassroots awareness of clinical research as a care option within local communities.
Recipharm has established a Brexit taskforce and plans to hire additional staff to navigate any potential effects of the UK’s departure from the EU in less than a year.
Elligo Health Research has acquired ePatientFinder’s Clinical Trial Exchange technology platform and referring practice network as it aims to continue expanding its own network.
The global cancer drug market is expected to reach $200bn by 2022 as the industry experiences rapid changes in treatment guidelines and pathways – and increasing complexity, says Iqvia exec.
LabConnect has completed phase one of three to increase its capacity for peripheral blood mononuclear cell (PBMC) processing at its facility in Johnson City, TN.
WCG has opened a new office in Tokyo, Japan that will serve as a center of excellence for its patient engagement group and house the company’s clinical services division in Asia.
